Amedica to Divest Spine Business to CTL Medical

CTL Medical will acquire the commercial spine business of Amedica (AMDA) via asset purchase agreement for US $10.0MM. The transaction is slated to close within 3Q18. For 2017, AMDA posted product revenue of 11.2MM, -26% vs. 2016.

CTL will exclusively own the portfolio of AMDA's metal and silicon nitride (SiNi) spine devices, and will have...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us